Warren And Markey Demand Transparency Over FDA Decision To Authorize Plasma Treatment
The Massachusetts Democrats requested communications between the agency and the White House to see whether the authorization was politically motivated.
Sens. Elizabeth Warren and Ed Markey are demanding the U.S. Food and Drug Administration provide all communications between the agency and the White House to determine whether the recent emergency use authorization of convalescent plasma treatment for coronavirus patients was politically motivated.
In a letter to the agency obtained by HuffPost on Tuesday, the Massachusetts Democrats called the FDA’s authorization decision “troubling,” given limited evidence of the treatment’s effectiveness on COVID-19 patients. The EUA allows for the distribution of convalescent plasma from people who have recovered from COVID-19 in the U.S. and for health care providers to administer it as appropriate to treat patients hospitalized who have or are suspected of having the disease.
Read the full article on the Huffington Post website here.
By: Sanjana Karanth
Source: Warren And Markey Demand Transparency Over FDA Decision To Authorize Plasma Treatment
Next Article Previous Article